Johnson and Johnson vaccine produced strong immune response, early results say

Early results from a Phase 1/2a clinical trial shows it was well tolerated and even one dose appeared to produce a strong immune response in almost all of the 800 participants.

Leave a Reply

Your email address will not be published. Required fields are marked *